Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-10-01
1987-09-22
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514297, 514786, 514787, 546 79, 546 93, 546105, 546106, 558411, 558413, 558423, 558425, A61K 3147, C07D21910
Patent
active
046955739
ABSTRACT:
There are disclosed compounds having the formula ##STR1## wherein n is 1, 2 or 3; X is hydrogen, loweralkyl, loweralkoxy, halogen, hydroxy, nitro, trifluoromethyl, NHCOR.sub.2 where R.sub.2 is loweralkyl, or NR.sub.3 R.sub.4 where R.sub.3 and R.sub.4 are independently hydrogen or loweralkyl; R is hydrogen or loweralkyl; R.sub.1 is hydrogen, loweralkyl, diloweralkylaminoloweralkyl, arylloweralkyl, diarylloweralkyl, furylloweralkyl, thienylloweralkyl, oxygen-bridged arylloweralkyl, oxygen-bridged diarylloweralkyl, oxygen-bridged furylloweralkyl or oxygen-bridged thienylloweralkyl; Y is C.dbd.O or CR.sub.5 OH where R.sub.5 is hydrogen or loweralkyl; Z is CH.sub.2 or C.dbd.CR.sub.6 R.sub.7 where R.sub.6 and R.sub.7 are independently hydrogen or loweralkyl; or Y and Z taken together is CR.sub.5 .dbd.CH where CR.sub.5 and CH correspond to Y and Z respectively; an optical antipode thereof, or a pharmaceutically acceptable acid addition salt thereof, which are useful for enhancing memory, methods for synthesizing them, and pharmaceutical compositions comprising an effective memory enhancing amount of such a compound.
REFERENCES:
patent: 3033866 (1962-05-01), Saggiomo et al.
patent: 3122553 (1964-02-01), Seneca
patent: 3232945 (1966-02-01), Sigal, Jr. et al.
patent: 3318896 (1967-05-01), Pribyl et al.
patent: 4284627 (1981-08-01), Raether et al.
patent: 4550113 (1985-10-01), Lavretskaya et al.
patent: 4631286 (1986-12-01), Shutske et al.
Magidson, et al., Chemical Abstracts, vol. 31, 58007 (1937).
Sargent, et al., J. Org. Chem., vol. 11, pp. 350-362 (1946).
Sargent, et al., J. Org. Chem., vol. 12, pp. 567-570, 571-576, (1947).
Sargent, et al., J. Org. Chem., vol. 12, pp. 571-576 (1947).
Stephen, et al., J. Chem. Soc. (1947), pp. 1034-1039.
Desai, et al., J. Indian Chem. Soc., vol. 37, No. 9, pp. 553-556 (1960).
Steinberg, et al., J. Med. Chem., vol. 18, No. 11, pp. 1056-1061 (1975).
Brian, et al., Chemical Abstracts, vol. 62, 6459e (1965).
Albert, The Acridines, 2nd ed., St Martins Press, N.Y. (1966), pp. 431-432.
Patnaik, et al., J. Med. Chem., vol. 9, pp. 483-488 (1966).
Konshin, et al., Chemical Abstracts, vol. 76, 34080k (1972).
Konshin, et al., (T') Chemical Abstracts, vol. 81, 120411d (1974).
Koupilova, et al., Chemical Abstracts, vol. 96, 155388p (1982).
Brian, et al., (II) J. Med. Chem., vol. 8, pp. 143-144 (1965).
Konshin et al., Khim Farm Zh, vol. 5, No. 11, pp. 10-12 (1971).
Davies, Drug Development Research, vol. 5, pp. 69-76 (1985).
Johns, et al., Drug Development Research, vol. 5, pp. 77-96 (1985).
Ellman, et al., Biochemical Pharmacology, vol. 7, pp. 88-95 (1961).
Schindler, et al., Drug Development Research, vol. 4, pp. 567-576 (1984).
Bartus, et al., Science, vol. 209, pp. 301-303 (07/11/80).
Broekkamp, et al., Psychopharmacology, vol. 83, pp. 122-125 (1984).
Komiskey, et al., Psychopharmacology, vol. 73, pp. 304-305 (1981).
Pierrat Frank A.
Shutske Gregory M.
Daus Donald G.
Hoechst-Roussel Pharmaceuticals Inc.
Ikeda Tatsuya
Rivers D.
LandOfFree
9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2058896